Cisplatin-Based Neoadjuvant Chemotherapy and Combined Resection for Ethmoid Sinus Adenocarcinoma Reaching and/or Invading the Skull Base
- 1 July 1996
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 122 (7) , 765-768
- https://doi.org/10.1001/archotol.1996.01890190061014
Abstract
Objective: To review our experience with cisplatin-based neoadjuvant chemotherapy before en bloc resection via a combined neurosurgical and transfacial approach for ethmoid sinus adenocarcinoma reaching and/or invading the skull base. Design: Case series. Setting: A tertiary care center and university teaching hospital. Patients: Twenty-two patients with primary untreated ethmoid sinus adenocarcinoma reaching and/or invading the skull base consecutively treated between 1984 and 1992 with cisplatin-based neoadjuvant chemotherapy and combined neurosurgical and transfacial approach. Main Outcome Measures: Statistical analysis of survival, local control, nodal recurrence, distant metastasis, and metachronous second primary tumor incidence based on the Kaplan-Meier actuarial method. Univariate analysis was performed to analyze the relationships between various factors, survival, and local recurrence. Clinical response, histological response, toxic effects of chemotherapy, and postoperative course were also reported. Results: The Kaplan-Meier 3-year survival, local control, nodal recurrence, and distant metastasis estimates were 68.1%, 65.7%, 5.3%, and 10%, respectively. Metachronous second primary tumor was not encountered in our series. Survival was statistically more likely to be reduced in patients with intrasphenoidal tumor extent (P=.04) and local recurrence (P=.01). Local recurrence was statistically more likely in patients with intrasphenoidal tumor extent (P=.002) and no response to cisplatin-based neoadjuvant chemotherapy (P=.03) Conclusions: The results achieved suggest that cisplatin-based neoadjuvant chemotherapy before combined neurosurgical and transfacial approach should be further investigated for the treatment of ethmoid sinus adenocarcinoma reaching and/or invading the skull base. Arch Otolaryngol Head Neck Surg. 1996;122:765-768Keywords
This publication has 12 references indexed in Scilit:
- Adenocarcinoma of the ethmoid sinusHead & Neck, 1995
- Factors Influencing Survival in Ethmoid Sinus CancerJAMA Otolaryngology–Head & Neck Surgery, 1992
- Prognostic factors in craniofacial surgeryThe Laryngoscope, 1991
- Adenocarcinoma of the ethmoid sinuses in High Wycombe 1986The Journal of Laryngology & Otology, 1989
- Carcinoma of the ethmoid sinusAmerican Journal of Otolaryngology, 1986
- Adenocarcinoma of the ethmoid sinuses. A review of 28 cases with special reference to wood dust exposureCancer, 1984
- Cancer of the nasal cavity and ethmoid/sphenoid sinusesCancer, 1979
- Adenocarcinoma of the para-nasal sinusesThe Journal of Laryngology & Otology, 1976
- The ethmoid sinuses: A re-evaluation of surgical resectionThe American Journal of Surgery, 1973
- Cancer of the Ethmoid SinusesJAMA Otolaryngology–Head & Neck Surgery, 1961